EUVIMEDOpdag EUVIMED
Open access

Distinguishing Isomeric Cyclobutane Thymidine Dimers by Ion Mobility and Tandem Mass Spectrometry

Hsin-Chieh Yang, Savannah S Scruggs iD, Mengqi Chai iD, George Mathai, John-Stephen Taylor iD, Michael L Gross iD

Journal of the American Society for Mass Spectrometry · 2024

DOI: 10.1021/jasms.4c00133 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, 2024. Written by Hsin-Chieh Yang and 5 co-authors. Institution: Department of Chemistry Washington University in St. Louis, St. Louis, Missouri 63130, United States. Major MEDLINE topics: Tandem Mass Spectrometry, Pyrimidine Dimers, Ion Mobility Spectrometry. Cited 2 times so far (Crossref); 37 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIH HHS, Division of Chemistry.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Irradiation of the major conformation of duplex DNA found in cells (B form) produces cyclobutane pyrimidine dimers (CPDs) from adjacent pyrimidines in a head-to-head orientation (syn) with the C5 substituents in a cis stereochemistry. These CPDs have crucial implications in skin cancer. Irradiation of G-quadruplexes and other non-B DNA conformations in vitro produces, however, CPDs between nonadjacent pyrimidines in nearby loops with syn and head-to-tail orientations (anti) with both cis and trans stereochemistry to yield a mixture of six possible isomers of the T=T dimer. This outcome is further complicated by formation of mixtures of nonadjacent CPDs of C=T, T=C, and C=C, and successful analysis depends on development of specific and sensitive methods. Toward meeting this need, we investigated whether ion mobility mass spectrometry (IMMS) and MS/MS can distinguish the cis,syn and trans,anti T=T CPDs. Ion mobility can afford baseline separation and give relative mobilities that are in accord with predicted cross sections. Complementing this ability to distinguish isomers is MS/MS collisional activation where fragmentation also distinguishes the two isomers and confirms conclusions drawn from ion mobility analysis. The observations offer early support that ion mobility and MS/MS can enable the distinction of DNA photoproduct isomers.

Subjects

MeSH terms (MEDLINE)

Tandem Mass SpectrometryPyrimidine DimersIon Mobility SpectrometryIsomerismDNACyclobutanesThymidine

Author keywords

Cyclobutane pyrimidine dimersDNA photoproductdensity functional theoryenergy-resolved spectraion mobility mass spectrometryion-neutral complexisomeric oligonucleotidesoligonucleotide adductstandem mass spectrometry

Substances

Pyrimidine DimersDNACyclobutanesThymidine

Authors and institutions

  • Department of Chemistry Washington University in St. Louis, St. Louis, Missouri 63130, United States.

ORCID profiles: Savannah S Scruggs, Mengqi Chai, John-Stephen Taylor, Michael L Gross

Funding

  • NIGMS NIH HHS
  • NIH HHS
  • Division of Chemistry
  • Pfizer
  • National Institute of General Medical Sciences

Cite

APA

Yang, H. C., Scruggs, S. S., Chai, M., Mathai, G., Taylor, J. S., & Gross, M. L. (2024). Distinguishing Isomeric Cyclobutane Thymidine Dimers by Ion Mobility and Tandem Mass Spectrometry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.4c00133

Vancouver

Yang HC, Scruggs SS, Chai M, Mathai G, Taylor JS, Gross ML. Distinguishing Isomeric Cyclobutane Thymidine Dimers by Ion Mobility and Tandem Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2024. doi:10.1021/jasms.4c00133

BibTeX
@article{Yang2024,
  author = {Yang, Hsin-Chieh and Scruggs, Savannah S and Chai, Mengqi and Mathai, George and Taylor, John-Stephen and Gross, Michael L},
  title = {Distinguishing Isomeric Cyclobutane Thymidine Dimers by Ion Mobility and Tandem Mass Spectrometry},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2024},
  doi = {10.1021/jasms.4c00133}
}
Start for free →